Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study - Hofman, MS; Lawrentschuk, N; Francis, RJ (Lancet, 2020)